MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Treatments

Home
Treatments
fatigue

Treating Fatigue in Multiple Sclerosis

MStranslate
July 20, 2021
Fatigue, Research, Symptoms, Treatments
Fatigue.  It is one of the most commonly reported symptoms by people living with multiple sclerosis (MS).  Not only do many people experience it, but they also indicate that it is the symptom that has the...
AstraZeneca Vaccine

Safety of AstraZeneca COVID-19 Vaccine in PwMS

MStranslate
June 7, 2021
COVID-19, Infection, Research, Treatments
2 Comments
One of the most common questions that I have received from the MStranslate community lately is whether there is any new information about the COVID vaccines for people living with multiple sclerosis. Last...
sex differences

Sex Differences in MS: Professor Rhonda Voskuhl

MStranslate
April 16, 2021
Research, Treatments, Videos
This week, we premiered our first collaborative project with RealTalk MS, an interview co-hosted by Brett Drummond and Jon Strum. Their very special guest for this inaugural event was Prof Rhonda Voskuhl...
mRNA vaccines

mRNA Vaccines & Their Potential in MS

MStranslate
January 15, 2021
Research, Treatments, Videos
Recently published research from the University Medical Center of the Johannes Gutenberg University has looked at the use of an mRNA vaccine as a potential treatment for multiple sclerosis. In this below...
cannabis oils

Cannabis Oils & Pomegranate Peel Extract

MStranslate
January 6, 2021
Research, Treatments
Happy New Year everyone!  We hope that 2021 is a fantastic year and that we see lots of positive developments in the field of multiple sclerosis research.  For the first time last year, we trialled an...
research update

Multiple Sclerosis Research Update – December 2020

MStranslate
December 15, 2020
Progressive MS, Research, Stem Cells, Treatments
With the end of 2020 approaching (I don’t think anyone is going to miss it), we thought we would try out a new style of research update.  Generally, our articles are an in-depth look at a specific study...
millennium

MS Research in the New Millennium: 2000 – 2020

MStranslate
July 23, 2020
Research, Treatments
It’s been 20 years since the world nervously welcomed the new millennium.  Let’s look back on those two decades and examine the major developments in Multiple Sclerosis research and treatment. Twenty...
bile acids

Bile Acids May Play Role in Multiple Sclerosis

MStranslate
June 23, 2020
Research, Treatments
2 Comments
Research Summary: Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation A joint investigation undertaken by researchers at Johns Hopkins University, the...
Ursolic acid

Fruit Peel Compound Shows Treatment Potential

MStranslate
April 7, 2020
Research, Treatments
Research Summary:  A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination A newly published study in the highly respected medical journal,...
mesenchymal stem cell

Mesenchymal Stem Cell Trial for Multiple Sclerosis

MStranslate
February 2, 2020
Conferences, Dr Travis Stiles, ECTRIMS, Stem Cells, Treatments
EXCLUSIVE INTERVIEW At ECTRIMS Congress 2019, we had the privilege of interviewing Prof. Dimitrios Karussis (Neurologist, Hadassah Hospital) about the exciting results from his mesenchymal stem cell trial...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.